← Back to Index

GCC Nurse Antenatal Guide

Routine Antenatal Care, Monitoring & GCC Maternity Context

Obstetrics & Midwifery

Gestational Age Calculator — Naegele's Rule

Gestational Age
Trimester
Estimated Due Date (EDD)
Expected SFH (cm)
Gestational Age — Core Concepts
Naegele's Rule (EDD)
EDD = LMP + 9 months + 7 days
OR LMP − 3 months + 7 days + 1 year
  • Based on 28-day cycle; adjust +1 day per extra cycle day >28
  • Accurate within ±2 weeks in first trimester USS
  • Ultrasound EDD preferred if LMP uncertain or irregular cycles
  • Dating scan (CRL at 8–13+6 weeks) is gold standard
Trimesters & Key Milestones
  • T1: 0–13+6 weeks — organogenesis, viability threshold
  • T2: 14–27+6 weeks — growth phase, fetal movements felt ~18–20 wks
  • T3: 28–40+6 weeks — maturation, lung surfactant from ~34 wks
  • Post-dates: >40+0; post-term >42+0 weeks
  • Preterm: <37+0 weeks; extreme preterm <28 weeks
Symphysis-Fundal Height (SFH)
SFH Measurement Technique

Measure from symphysis pubis to uterine fundus with tape; record in cm.

SFH (cm) ≈ Gestational Weeks (±2 cm after 20 weeks)
  • Meaningful from 20 weeks onwards
  • <10th centile on customised chart → SGA / IUGR concern
  • >90th centile → macrosomia, polyhydramnios, multiple
  • Plot on customised growth chart (GROW / Intergrowth-21)
Causes of SFH Discrepancy
Small: IUGR, oligohydramnios, incorrect dates, transverse lie

Large: Macrosomia, polyhydramnios, multiple pregnancy, fibroid, incorrect dates
Leopold's Manoeuvres
Four-Step Abdominal Palpation
ManoeuvrePositionTechniqueDetermines
1st — Fundal GripFace patientPalpate fundus with both hands cuppedWhich fetal pole is at fundus (head = hard, round; breech = soft, irregular)
2nd — Lateral GripFace patientHands slide to sides of uterus, one steadies, one palpatesFetal back (smooth, firm) vs limbs (knobby, irregular) — fetal lie
3rd — Pawlick's GripFace patientThumb and fingers grasp presenting part above symphysisPresenting part, engagement (mobile = not engaged)
4th — Pelvic GripFace patient's feetFingers point caudally, deep palpation lateral to midlineDegree of descent / engagement; cephalic prominence
Fetal Lie
Longitudinal (cephalic/breech) — normal
Transverse — requires ECV or LSCS
Oblique — usually transient
Engagement (Fifths Palpable)
5/5 = fully above brim (not engaged)
3/5 = just engaging
0/5 = fully engaged (not palpable)
Foetal Heart Rate Auscultation
Normal FHR Parameters
Normal FHR: 110–160 bpm
  • Tachycardia >160 bpm — infection, maternal pyrexia, drugs, hypoxia
  • Bradycardia <110 bpm — cord compression, prolonged deceleration
  • Listen for 1 full minute with Pinard / 60-second Doppler count
  • Auscultate after uterine contraction in labour
Pinard vs Doppler
FeaturePinard HornHand-held Doppler
First heard~20 weeks~12 weeks
BatteryNone neededRequired
FHR displayAuscultation onlyDigital readout
Best forExperienced midwivesCommunity / student use
Maternal Vital Signs in Pregnancy
ParameterNon-PregnantPregnant ChangesClinical Note
Blood Pressure120/80 mmHgBP falls in T2 (nadir ~20 wks), rises back T3Diastolic <80 common in T2; >140/90 = hypertension
Heart Rate60–90 bpm+10–20 bpm increaseResting tachycardia can be normal; exclude PE if sudden
Respiratory Rate12–16/minIncreases; tidal volume ↑40%Dyspnoea common; exclude PE/pulmonary oedema
Temperature36.5–37.2°CMild rise in T1 (progesterone)Fever ≥38°C requires urgent assessment
SpO297–100%Unchanged or slightly ↑SpO2 <95% warrants assessment
Blood pressure should always be measured after 5 minutes of rest, in a seated position with the arm at heart level. Automated BP machines may underread in severe pre-eclampsia — use calibrated mercury or aneroid sphygmomanometer if in doubt.
Antenatal Booking Bloods
TestTimingPurpose
FBCBooking & 28 wksAnaemia (Hb <110 g/L in T1/T3, <105 g/L in T2); platelets
Blood group & Rh antibodiesBooking & 28 wksRh(D) status; alloantibody screen for HDFN risk
Rubella immunityBookingIdentify susceptible women; vaccinate postnatally
Syphilis (VDRL/TPPA)BookingCongenital syphilis prevention
Hepatitis B (HBsAg)BookingNeonatal immunoprophylaxis planning
HIVBooking (offer)MTCT prevention; antiretrovirals if positive
Varicella titreBooking if no historySusceptibility — VZIG if exposed; no live vaccine in pregnancy
Thyroid function (TSH)Booking (symptomatic/high-risk)Hypothyroidism common; target TSH <2.5 in T1
Urine M,C&SBookingAsymptomatic bacteriuria — treat to prevent pyelonephritis/preterm
Random/fasting glucose or HbA1cBooking (GCC protocol)Early GDM detection given high GCC prevalence
First Trimester Combined Screening
Nuchal Translucency + Biochemistry (11–13+6 weeks)
  • NT thickness (USS) — normal <3.5 mm at CRL 45–84 mm
  • PAPP-A (pregnancy-associated plasma protein-A) — ↓ in T21, T18, T13
  • Free beta-hCG — ↑ in Down syndrome (T21)
  • Combined risk calculation (FMF algorithm)
  • Cut-off: ≥1:150 = high-risk → offer invasive testing
  • Low-risk <1:1000; intermediate 1:150–1:1000
Cell-free fetal DNA (cfDNA / NIPT) available in GCC private hospitals. Sensitivity >99% for T21. Not routine nationally but offered privately. PPV depends on prevalence.
Chromosomal Conditions Screened
Trisomy 21 (Down syndrome)
Trisomy 18 (Edwards syndrome)
Trisomy 13 (Patau syndrome)
Turner syndrome (45,X)
Triploidy
Diagnostic Options if High-Risk
CVS (10–14 wks): faster result, higher loss rate (~1%)
Amniocentesis (15–20 wks): lower loss rate (~0.5%)
Anomaly Scan (18–20 Weeks)
Structures Evaluated

Head & Spine

  • Head shape & size (BPD/HC)
  • Cavum septum pellucidum
  • Cerebellum / cisterna magna
  • Nuchal fold (<6 mm)
  • Spine — neural tube defects

Face, Chest & Abdomen

  • Lips / profile (cleft lip)
  • 4-chamber heart view
  • LVOT & RVOT outflow tracts
  • Diaphragm integrity
  • Stomach bubble (swallowing)
  • Abdominal wall / cord insertion

Limbs & Placenta

  • Femur / humerus length
  • Hands and feet (bilateral)
  • Kidneys & bladder
  • Placental site & cord vessels
  • Amniotic fluid index
Gestational Diabetes Mellitus (GDM) Screening
75g OGTT — IADPSG Criteria (GCC Standard)
GCC has one of the highest GDM prevalence rates globally (20–25%). Universal OGTT is recommended for all pregnant women at 24–28 weeks; high-risk women (obesity, family history, prior GDM) screened at booking.
TimepointGDM Diagnostic Threshold (IADPSG)Normal
Fasting≥ 5.1 mmol/L<5.1 mmol/L
1-hour post-load≥ 10.0 mmol/L<10.0 mmol/L
2-hour post-load≥ 8.5 mmol/L<8.5 mmol/L

ONE abnormal value is sufficient for GDM diagnosis (IADPSG 2010). WHO 2013 aligns with IADPSG. GDM management: dietary modification, SMBG, insulin or metformin if targets not met (FBG <5.3, 1h PP <7.8, 2h PP <6.7 mmol/L).

Group B Streptococcus (GBS) Screening
Screening Protocol
  • Vaginal-rectal swab at 35–37 weeks
  • Culture on selective broth medium
  • GBS+ or unknown status → intrapartum IAP
  • IAP: Benzylpenicillin 3g IV loading, then 1.5g 4-hourly in labour
  • Penicillin allergy (low risk): cefazolin; high-risk allergy: clindamycin or vancomycin per sensitivities
Risk Factors for Neonatal GBS Disease
Previous infant with GBS disease
GBS bacteriuria this pregnancy
Preterm labour (<37 weeks)
Prolonged ROM (>18 hours)
Intrapartum fever ≥38°C
Blood Group, Rhesus & Anti-D Prophylaxis
Antibody Screening Schedule
  • ABO & Rh(D) at booking
  • Indirect Coombs (IAT) at booking & 28 weeks
  • Significant alloantibodies: serial titres, MCA Doppler for fetal anaemia
  • Anti-D, anti-c, anti-Kell — highest HDFN risk
Anti-D Immunoglobulin
  • Rh(D) negative women, non-sensitised only
  • Routine antenatal anti-D prophylaxis (RAADP): 1500 IU at 28 weeks (or 500 IU at 28 & 34 wks)
  • Additional anti-D after sensitising events: miscarriage >12 wks, APH, amniocentesis, ECV, trauma
  • Postnatal: 500 IU within 72 hours if baby Rh+
  • Kleihauer-Betke test for large FMH (>4 mL) → dose adjustment
Routine Antenatal Visit Schedule (GCC Context)
8
8–10 Weeks — Booking Visit
History, BP, weight, BMI, booking bloods, USS dating, MSU, urine protein/glucose, prescribe folic acid (400 mcg/d, 5 mg if high-risk)
12
11–13+6 Weeks — First Trimester Screen
NT scan, PAPP-A/beta-hCG, Down's risk calculation, discuss NIPT if desired
16
16 Weeks
Review results, BP, FH auscultation, SFH, any concerns, RAADP if Rh-negative
20
18–20 Weeks — Anomaly Scan
Detailed fetal anatomy survey, placental localisation, AFI
24
24–28 Weeks — GDM Screen
75g OGTT, FBC, antibody screen, SFH, BP, fetal movements counselling
28
28 Weeks
Anti-D if Rh−, repeat FBC & antibodies, growth USS if indicated, RAADP 1500 IU
34
34–36 Weeks
SFH, presentation check, birth plan discussion, GBS swab, USS if growth concern
38
38–40 Weeks
Bishop's score assessment, induction counselling, antenatal CTG if high-risk
Hyperemesis Gravidarum (HG)
Diagnosis & Assessment
HG affects ~1% of pregnancies but is the leading cause of first-trimester hospital admission. Defined as intractable vomiting + ≥5% weight loss + ketonuria requiring IV treatment.

PUQE Score (Pregnancy Unique Quantification of Emesis)

  • Hours of nausea, episodes of vomiting, episodes retching scored 1–5 each
  • Mild ≤6, Moderate 7–12, Severe ≥13
  • Assess: U&E, LFTs, TFTs, urinalysis (ketones), weight
Wernicke's Encephalopathy Prevention
Thiamine (Vitamin B1) deficiency risk with prolonged vomiting.
Give IV Thiamine (Pabrinex) BEFORE IV glucose / dextrose in all HG patients.
Triad: confusion, ophthalmoplegia, ataxia — irreversible if missed.
TreatmentDosage / RouteNotes
IV FluidsHartmann's or NS 1L 4–6-hourlyCorrect electrolytes; avoid dextrose without thiamine
Thiamine (Pabrinex)IV Pabrinex I+II 8-hourly × 3 doses then oral thiamine 100 mg TDSBEFORE any IV glucose
Ondansetron4–8 mg IV/oral 8-hourlyAvoid in T1 if possible; caution cardiac QT; not first-line
Cyclizine50 mg IV/IM/oral 8-hourlyFirst-line antiemetic; safe in T1
Metoclopramide10 mg IV/oral 8-hourlyEPS risk; limit to 5 days
Promethazine25 mg oral/IM nocteSedating; useful if sleep disrupted
LMWHEnoxaparin 40 mg SC dailyThromboprophylaxis if hospitalised; high VTE risk in HG
NG/TPNNasogastric/parenteralRefractory cases; involve dietitian
Pre-Eclampsia
Diagnostic Criteria
Pre-eclampsia remains a leading cause of maternal and perinatal mortality in the GCC. ISSHP 2018 definition: new-onset hypertension ≥140/90 mmHg after 20 weeks PLUS at least one of: proteinuria, maternal organ dysfunction, or uteroplacental dysfunction.

Severe Features — escalate immediately

  • BP ≥160/110 mmHg sustained
  • Headache unresponsive to analgesia
  • Visual disturbances (scotomata, photopsia)
  • Epigastric / right upper quadrant pain (hepatic capsule)
  • Creatinine >90 μmol/L or oliguria <25 mL/h
  • Platelets <100 × 10⁹/L (HELLP)
  • ALT/AST >2× upper limit normal
  • Pulmonary oedema / SpO2 <95%
  • Eclamptic seizure
Magnesium Sulphate Regimen (Eclampsia Prophylaxis)
Loading: MgSO4 4g IV over 5–10 min
Maintenance: 1 g/h IV infusion for 24h after delivery or last seizure
Monitor: RR ≥12/min, urine output ≥25 mL/h, patellar reflexes present
Toxicity antidote: Calcium gluconate 10 mL of 10% IV over 3 min
Antihypertensives in Pregnancy
Acute: Labetalol 200 mg oral / 50 mg IV
Acute: Hydralazine 5–10 mg IV, repeat 20-min
Acute: Nifedipine 10 mg oral (not sublingual)
Maintenance: Labetalol / Methyldopa / Nifedipine LA
Avoid: ACE inhibitors, ARBs, thiazides
SeverityBP ThresholdDelivery Timing
Non-severe pre-eclampsia140–159/90–10937+0 weeks (NICE) or 37–38 weeks per local protocol
Severe / HELLP / eclampsia≥160/110 or organ dysfunctionExpedite delivery after stabilisation regardless of gestation
Very preterm (<34 wks)AnyCorticosteroids + MgSO4 neuroprotection, aim 48h if maternal/fetal condition allows
Intrauterine Growth Restriction (IUGR)
Classification & Causes
  • Early-onset IUGR: <32 weeks — usually placental insufficiency; worse prognosis
  • Late-onset IUGR: ≥32 weeks — often constitutionally small vs truly growth-restricted
  • Fetal causes: chromosomal anomaly, structural defect, infection (CMV, toxoplasma)
  • Placental: insufficiency, praevia, abruption, mosaicism
  • Maternal: pre-eclampsia, chronic hypertension, DM, renal disease, SLE, antiphospholipid syndrome, smoking, substance use
Surveillance Protocol
Doppler Velocimetry Stages
Stage 1: Umbilical Artery PI >95th centile
Stage 2: Absent/reversed EDF in UA
Stage 3: Ductus Venosus PI ↑ or absent a-wave
Stage 4: CTG decelerations — delivery usually indicated
Surveillance: 2× weekly USS + Doppler for IUGR <34 wks
Placenta Praevia
ABSOLUTE RULE: NO vaginal examination in any woman with suspected placenta praevia until placental site is confirmed by USS. Digital VE can precipitate catastrophic haemorrhage.
Classification
  • Grade I (Low-lying): lower edge <20 mm from internal os
  • Grade II (Marginal): reaches os
  • Grade III (Partial): partially covers os
  • Grade IV (Complete/Major): completely covers internal os
  • Suspected on 20-week scan → transvaginal USS at 32–36 weeks
Management
  • Major praevia (grade III/IV) → elective LSCS at 36–37 weeks
  • Admit if bleeding — IV access, cross-match, Rh prophylaxis if Rh-
  • Corticosteroids if <34 weeks and significant bleeding
  • Pelvic rest — no intercourse, no VE, no tampons
  • Counsel on Morbidly Adherent Placenta risk (praevia + previous LSCS scar)
  • MAP protocol if massive obstetric haemorrhage: call for help, 2× large-bore IV, fluid resuscitation, activate MHP, blood products 1:1:1 ratio
Antenatal CTG Interpretation
Four Features — DR C BRAVADO Framework
FeatureNormal (Reassuring)Non-ReassuringAbnormal
Baseline FHR110–160 bpm100–109 or 161–180 bpm<100 or >180 bpm; sinusoidal ≥10 min
Variability≥5 bpm over 1-min segments3–4 bpm for 30–90 min<3 bpm for >30 min; or ≥25 bpm >10 min
Accelerations≥2 in 20 min, ≥15 bpm × ≥15 secNone in 40–80 minNone for >90 min (at term)
DecelerationsEarly decels (benign, vagal)Variable decels; late decels <3 in 30 minLate decels >3 in 30 min; prolonged >3 min; atypical variable
Normal CTG — All 4 features reassuring
Continue routine monitoring. Reassess as clinically indicated.
Suspicious CTG — 1 non-reassuring feature
Identify cause. Increase frequency of monitoring. Consider further evaluation (BPP, Doppler).
Pathological CTG — ≥2 non-reassuring OR ≥1 abnormal feature
Urgently assess fetal wellbeing. Position left lateral. IV fluids. Oxygen only if hypoxaemic. Stop oxytocin. Prepare for emergency delivery. FBS or expedite delivery.
Biophysical Profile (BPP)
Five Parameters — Score /10
ParameterScore 2 (Normal)Score 0 (Abnormal)
NST (CTG)≥2 accelerations in 20–40 min<2 accelerations
Fetal Breathing≥1 episode ≥30 sec in 30 minAbsent or <30 sec
Fetal Movement≥3 discrete movements in 30 min<3 movements
Fetal Tone≥1 extension + return to flexion (limb or trunk)Slow extension, no return, absent
Amniotic Fluid≥1 pocket ≥2 cm in 2 perpendicular planesAbsent / largest pocket <2 cm
Score 8–10/10
Normal — repeat in 1 week (or per indication)
Score 6/10
Equivocal — reassess in 6 hours; consider delivery if ≥36 weeks or oligohydramnios
Score ≤4/10
Deliver regardless of gestational age
Fetal Movement Monitoring
Cardiff Count-to-Ten Method
  • Count from 9 am daily in left lateral position after meal
  • Record time to reach 10 movements
  • <10 movements in 12 hours → urgent assessment
  • Normal: most women reach 10 by midday
  • Do not use alcohol / cold drinks to provoke movement
  • Inform all women to report reduced movement from 24 weeks
Reduced Fetal Movement — Assessment Pathway
  • History: duration, gestation, risk factors
  • Auscultation / Doppler FHR immediately
  • CTG ×20–30 min (term); BPP if CTG concerns
  • USS: AFI, growth, Doppler if <28 wks or IUGR
  • Reassure if normal, and advise to re-attend if recurrence
  • Second episode RFM: MCA Doppler, Kleihauer test, consider LSCS timing
Fetal Growth Assessment
Hadlock Biometry Formula & Classification
EFW (Hadlock 4) = 1.3596 − 0.00386(AC×FL) + 0.0064(HC) + 0.00061(BPD×AC) + 0.0425(AC) + 0.174(FL)
CentileClassificationAction
<3rdSevere SGA / IUGRIntensive surveillance; Doppler; likely early delivery
3rd–9thSGA — confirm IUGR by DopplerFortnightly USS; umbilical artery Doppler; growth chart
10th–90thAppropriate for gestational age (AGA)Routine monitoring
>90thLarge for gestational age (LGA)GDM screen; shoulder dystocia counselling; delivery planning
>97thMacrosomiaSenior obstetric review; consider elective LSCS if EFW >4.5 kg
Bishop's Score — Cervical Assessment
Modified Bishop's Score (0–13)
FeatureScore 0Score 1Score 2Score 3
Dilatation (cm)Closed1–2 cm3–4 cm≥5 cm
Effacement (%)0–30%40–50%60–70%≥80%
Station−3−2−1/0+1/+2
ConsistencyFirmMediumSoft
PositionPosteriorMidAnterior
Score 0–5 — Unfavourable
Cervical priming required (PGE2 / misoprostol / balloon catheter) before induction
Score 6–7 — Intermediate
May proceed with ARM ± oxytocin; senior review
Score ≥8 — Favourable
ARM suitable; proceed with induction; good predicted outcome
Labour Onset Types
Spontaneous vs Induced
  • Spontaneous: Regular painful contractions ≥3 in 10 min + cervical change
  • Induced: Artificial initiation — membrane sweep, PGE2, misoprostol, oxytocin infusion, ARM
  • Augmentation: Oxytocin to accelerate established labour
  • IOL indications: post-dates, GDM, pre-eclampsia, IUGR, PROM, reduced movements, IUD
Induction Methods
  • Membrane sweep from 38 weeks — 1st line non-pharmacological
  • Dinoprostone (PGE2) pessary/gel — unfavourable cervix
  • Misoprostol 25–50 mcg vaginal — WHO-endorsed alternative
  • Foley balloon catheter — mechanical, safe with previous LSCS
  • ARM (amniotomy) — only when head engaged, cervix ≥2 cm
  • Oxytocin infusion — after ARM, titrate per uterine response
VBAC — Eligibility Criteria
VBAC Suitable (Factors Favouring)
  • One previous lower segment LSCS (transverse)
  • No other uterine scar (previous rupture contraindicates)
  • No absolute indication for repeat LSCS this pregnancy
  • Previous vaginal birth — significantly improves success rate
  • Spontaneous labour onset preferred over IOL
  • Cephalic presentation, no CPD on clinical / X-ray
  • In-hospital delivery with CTG monitoring, anaesthesia and surgical team available
Uterine Rupture — Red Flags in VBAC
Sudden severe abdominal pain (scar pain between contractions)
Fetal bradycardia / pathological CTG
Vaginal bleeding
Loss of fetal station / presenting part retracts
Maternal shock → immediate laparotomy

VBAC success rate: ~72–75%. ELRCS risk vs VBAC risk — individualised counselling. In GCC, high elective LSCS rate limits VBAC uptake.

Epidural Analgesia — Process
  • Informed consent — documented; discuss risks (hypotension, dural puncture headache, motor block, prolonged labour, instrumental delivery risk)
  • IV access (large-bore) + preload 500 mL crystalloid
  • Continuous CTG during insertion and 30 min after each top-up
  • BP monitored q5 min × 15 min after each bolus
  • Hypotension (SBP <100 or >20% drop): IV fluid bolus, left lateral tilt, ephedrine/phenylephrine
  • Consent must be obtained when not in active severe pain — if patient requests before active labour, document when able to consent
Contraindications to Epidural
Patient refusal
Coagulopathy / platelets <75 × 10⁹/L
Local / systemic infection at insertion site
Raised ICP
Haemodynamic instability
Uncooperative patient
LMWH within 12 h (UFH within 4 h)
Birth Planning — GCC Cultural Considerations
Culturally Sensitive Planning
  • Female-only birth attendants — request documented and honoured where possible per local policy
  • Husband/mahram presence — standard in GCC; discuss preferences
  • Ramadan fasting — see GCC Context tab for specific guidance
  • Umbilical cord care per cultural/religious preference (delayed cutting, placenta disposal)
  • Islamic birth rites — Adhan in ear, tahneeq; coordinate with family
  • Language concordance — Arabic interpreter available if needed
Water Birth & Home Birth
GCC Water Birth Availability
Limited availability — select private hospitals (e.g., Mediclinic, Aster). Not widely available in public sector. Suitable for low-risk at-term women. Hydrotherapy in labour widely available even where water birth is not.
Home Birth — GCC Context
NOT recommended. All GCC governments mandate hospital-based delivery. Community/home birth not supported by healthcare systems. Advise all women on timely hospital attendance in early labour.

Pre-Eclampsia Risk Stratifier (FIGO/NICE)

Risk Category
Aspirin Recommendation
Aspirin Dose
Start From
GCC-Specific Epidemiology
GDM Epidemic
  • GCC prevalence: 20–25% of pregnancies
  • UAE, Saudi Arabia, Qatar ranked globally highest
  • High baseline T2DM rates (15–20% adult population)
  • Contributing: obesity, sedentary lifestyle, consanguinity, high multiparity, late childbearing
  • Universal 75g OGTT mandated in most GCC antenatal guidelines
  • Neonatal macrosomia & shoulder dystocia rates correspondingly elevated
High Caesarean Section Rates
  • GCC LSCS rates: 40–55%+ in many centres
  • WHO recommended rate: 10–15%
  • Drivers: maternal request, repeat LSCS, GDM/macrosomia, high IVF multiple gestation, defensive practice
  • Elective LSCS before 39 weeks associated with neonatal respiratory morbidity
  • Uterine scar complications (morbidly adherent placenta) increasing
  • Efforts to promote VBAC in GCC tertiary centres ongoing
Multiple Gestation & IVF
  • IVF/ART utilisation among highest globally in GCC (infertility stigma → high uptake)
  • Multiple pregnancy rate significantly higher than natural conception
  • Twin pregnancies: higher rates PE, GDM, preterm, IUGR, TTTS (monochorionic)
  • Single embryo transfer (SET) increasingly promoted to reduce multiples
  • Chorionicity assessment (10–14 wks USS) determines surveillance protocol
Ramadan Fasting in Pregnancy
Clinical Guidance for Muslim Pregnant Women
Fasting is an individual religious duty. Islam permits pregnant and breastfeeding women to break the fast if there is genuine harm risk (hardship / darar). The nurse's role is to provide evidence-based information and support informed decision-making — not to direct religious practice.

Risks to Discuss

  • GDM / existing DM: hypoglycaemia risk, glucose fluctuations; if on insulin or sulphonylurea — advise breaking fast; frequent SMBG
  • Dehydration: especially in summer months (GCC: 45°C+, >16 h fast)
  • Reduced fetal movements reported in some studies during Ramadan fasting — reassure but advise to monitor and report
  • Ketonaemia with prolonged fasting — fetal neurotoxic potential (observational data)
  • First trimester fasting & NTD — folic acid absorption concern
  • Iron / supplement absorption on empty stomach — advise timing with Iftar/Suhoor

Practical Recommendations

  • Low-GI, complex carbohydrates at Suhoor (pre-dawn meal)
  • Adequate hydration between Iftar and Suhoor
  • Avoid overcompensation with high-sugar Iftar foods (GDM risk)
  • Folic acid and iron at Suhoor or Iftar
  • Insulin regimens must be adjusted with diabetologist if fasting
  • If unwell, dizzy, contractions, reduced movements — break fast immediately
  • Increased kick count vigilance recommended
  • Third trimester fasting: more physiological stress — individualise counselling
Healthcare Access & Social Context
Nationals vs Expatriates
  • GCC nationals: free comprehensive antenatal care in government hospitals
  • Expatriates (majority of GCC population in UAE/Qatar/Kuwait): employer-sponsored or self-funded insurance; many use private hospitals
  • Undocumented/uninsured women: a vulnerable population — access to emergency obstetric care protected legally but routine care gaps exist
  • Cultural differences in disclosure of domestic violence, substance use — sensitive enquiry essential
  • Consanguinity common in some GCC populations — genetic counselling referral pathways important
Leading GCC Maternity Hospitals
HospitalCountrySpecialty
Latifa HospitalUAE (Dubai)High-risk obstetrics, NICU
Corniche HospitalUAE (Abu Dhabi)Largest delivery centre in Arab world
Al Ain Hospital (Tawam)UAETertiary referral, genetics
KFMC (King Fahad Medical City)Saudi ArabiaNational referral, MFM
Hamad Medical CorpQatarCorniche Hospital Doha
Mubarak Al-KabeerKuwaitMinistry, tertiary
Teenage & Adolescent Pregnancy
In some GCC regions, marriage and pregnancy in girls aged 15–18 (or younger in some jurisdictions) occurs, particularly in less urbanised areas. Legal age of marriage varies by GCC country (typically 15–18 with judicial consent). Nurses must be aware of increased obstetric risk and safeguarding obligations.

Obstetric Risks in Adolescent Pregnancy

  • Pre-eclampsia risk higher in young primiparas
  • Cephalopelvic disproportion / obstructed labour in girls with immature pelvis
  • Anaemia, nutritional deficiency
  • Preterm birth, SGA, low birthweight
  • Postpartum depression and social isolation

Nursing Responsibilities

  • Non-judgmental, culturally respectful communication
  • Assess for signs of coercion — document and escalate per local safeguarding policy
  • Additional psychosocial support referral
  • Nutritional optimisation — folate, iron, calcium
  • Senior obstetric review for all teenage pregnancies under 16
Practice MCQs — Antenatal Care
1. A woman's LMP was 1 January. Using Naegele's Rule, what is her EDD?
2. At 30 weeks gestation, what is the expected symphysis-fundal height range?
3. According to IADPSG criteria for the 75g OGTT, which fasting glucose value confirms GDM?
4. What is the antidote for magnesium sulphate toxicity?
5. A biophysical profile score of 4/10 should prompt which action?
6. Which Bishop's score indicates a cervix favourable for induction of labour?
7. In hyperemesis gravidarum, which treatment must be given BEFORE intravenous glucose to prevent Wernicke's encephalopathy?
8. What does the Cardiff Count-to-Ten method instruct a pregnant woman to do?
9. At what gestational age is GBS vaginal-rectal swab recommended?
10. A woman with placenta praevia presents with fresh vaginal bleeding at 32 weeks. What is the most important IMMEDIATE nursing action to avoid?